Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fabrication, refining and recycling of precious metals and their products. Johnson Matthey provides services such as refining, platinum marketing and distribution, chemical process technologies, contract manufacturing and Active pharmaceutical ingredients’ (APIs) contract research and development. Johnson Matthey serves environmental, automotive, chemical, medical, recycling, oil and gas and other industries. The company operates in the UK, Germany, the US, Mexico, Belgium, Russia, Japan, Malaysia, India, South Africa, China, Argentina, and South Korea. Johnson Matthey is headquartered in London, the UK. Johnson Matthey Plc (JMAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year... Research Beam Model: Research Beam Product ID: 1916439 250 USD New
Johnson Matthey Plc (JMAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Johnson Matthey Plc (JMAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : July   2017
  • Pages : 19
  • Publisher : GlobalData
 
 
 
Summary

Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fabrication, refining and recycling of precious metals and their products. Johnson Matthey provides services such as refining, platinum marketing and distribution, chemical process technologies, contract manufacturing and Active pharmaceutical ingredients’ (APIs) contract research and development. Johnson Matthey serves environmental, automotive, chemical, medical, recycling, oil and gas and other industries. The company operates in the UK, Germany, the US, Mexico, Belgium, Russia, Japan, Malaysia, India, South Africa, China, Argentina, and South Korea. Johnson Matthey is headquartered in London, the UK.

Johnson Matthey Plc (JMAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Johnson Matthey Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Intrexon and Johnson Matthey Enter into Agreement 9
Asset Transactions 9
Endo Pharma Acquires US Patents For Oxymorphone From Johnson Matthey 9
Acquisition 10
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 10
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 11
Alfa Aesar Acquires Biomedical Technologies 12
Johnson Matthey Plc - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Johnson Matthey Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Intrexon and Johnson Matthey Enter into Agreement 9
Endo Pharma Acquires US Patents For Oxymorphone From Johnson Matthey 9
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 10
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 11
Alfa Aesar Acquires Biomedical Technologies 12
Johnson Matthey Plc, Key Competitors 14
Johnson Matthey Plc, Key Employees 15
Johnson Matthey Plc, Subsidiaries 16List of Figures
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter